Sign in

CIK 0001615219

  • Non-accelerated filer
  • Smaller reporting company

Decoy Therapeutics Inc.

Sign in to watch
Ticker
DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465087339
Phone
+1 346-772-0346
Business address
2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
Former names
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 44 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-01-21 Hadfield Robert General Counsel & Secretary Grant or award · Stock Option (right to buy) +40,000 40,000
2015-12-14 Westphal Christoph H President and CEO Purchase +927 $12.01 $11K 3,925,248
2015-12-07 Westphal Christoph H President and CEO Purchase +907 $12.02 $11K 3,924,321
2015-11-30 Westphal Christoph H President and CEO Purchase +887 $12.32 $11K 3,923,414
2015-11-23 Westphal Christoph H President and CEO Purchase +971 $11.39 $11K 3,922,527
2015-11-19 KOZIN MARC D Director Purchase +4,500 $11.38 $51K 4,500
2015-11-11 HAHN MARINA President, Consumer Grant or award · Stock Option (right to buy) +150,000 150,000
2015-11-11 Lindemann Katharine Chief Operating Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2015-11-11 PEREZ ROBERT J Director Grant or award · Stock Option (right to buy) +20,000 20,000

Page 12 of 12 · 229 trades